<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03445455</url>
  </required_header>
  <id_info>
    <org_study_id>2017-A03560-53</org_study_id>
    <nct_id>NCT03445455</nct_id>
  </id_info>
  <brief_title>Assessment of Tidal Volume During Non Invasive Oxygenation Techniques</brief_title>
  <acronym>VOLHYPOX</acronym>
  <official_title>Assessment of Tidal Volume by Electrical Impendance Tomography During Non Invasive Oxygenation Techniques in de Novo Hypoxemic Acute Respiratory Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Henri Mondor University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Henri Mondor University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      High Tidal volume is one of the main mechanisms that lead to lung injuries under mechanical&#xD;
      ventilation (ventilator induced lung injury: VILI). It could also induce lung damage during&#xD;
      spontaneous or assisted ventilation (patient-self inflicted lung injury: P-SILI). Different&#xD;
      non invasive oxygenation devices are available to deliver oxygen during acute hypoxemic&#xD;
      respiratory failure: high concentration mask, high flow nasal canula and non-invasive&#xD;
      ventilation (with bucco-nasal mask or helmet). The investigators hypothesized that the device&#xD;
      may influence the tidal volume. Therefore, the objective of this study is to measure and&#xD;
      compare the tidal volume during the use of each device. Tidal volume will be measured using&#xD;
      Electrical impedence tomography.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background : De novo acute respiratory failure with moderate to severe hypoxemia is&#xD;
      associated with high intubation and mortality rates. Under non-invasive ventilation (NIV)&#xD;
      with a bucco-nasal mask, a high Tidal volume is associated with NIV failure and poor outcome.&#xD;
      It is suspected that non-control of the Tidal volume may worsen the prognosis of the patient.&#xD;
      Indeed, it is logical to consider that the physiopathological mechanisms that lead to&#xD;
      ventilator induced lung injury (VILI) under mechanical ventilation, especially&#xD;
      over-distension, can in the same way aggravate pulmonary lesions under NIV and even during&#xD;
      spontaneous breathing. The value of the Tidal volume is available in non-invasive ventilation&#xD;
      with the bucco-nasal mask, but it is unknown with the use of other non-invasive oxygenation&#xD;
      techniques : oxygen therapy with the high concentration mask, non-invasive ventilation with&#xD;
      the helmet, and high flow nasal canula.&#xD;
&#xD;
      Objectives : The main objective is to compare the Tidal volume received under different&#xD;
      oxygenation techniques (oxygen therapy with high concentration mask, NIV with bucco-nasal&#xD;
      mask and with helmet, high flow nasal canula), in patients with de novo acute hypoxemic&#xD;
      respiratory failure and moderate to severe hypoxemia.&#xD;
&#xD;
      Methods : All patients admitted in intensive care for de novo acute hypoxemic respiratory&#xD;
      failure, non hypercapnic, with moderate to severe hypoxemia (PiO2/FiO2 &lt; 200 mmHg) will be&#xD;
      included. Patients with one of the following items will be excluded : chronic respiratory&#xD;
      disease, cardiogenic pulmonary edema, hemodynamic instability, coma, contraindication to NIV,&#xD;
      indication for immediate intubation.&#xD;
&#xD;
      After inclusion, the Tidal volume will be measured for each technique with the use of&#xD;
      electrical impedance tomography, in a random order. Randomisation will be carried out by&#xD;
      using sealed envelopes containing a predetermined order. Each technique will be used for 15&#xD;
      minutes. For NIV with the bucco-nasal mask, the inspiratory pressure will be progressively&#xD;
      adjusted to maintain the Tidal volume between 6 and 8 ml/kg of ideal body weight without&#xD;
      dropping below 7 cm H2O and the positive expiratory pressure will be gradually increased to 5&#xD;
      cm H2O. For NIV with the helmet, the inspiratory pressure will be progressively increase to&#xD;
      12 cm H2O and the positive expiratory pressure will be gradually increased to 5 cm H2O. For&#xD;
      high flow nasal canula,the gas flow will be set at 50 L/minute. FiO2 will be adjusted to keep&#xD;
      SpO2 above 92%. To convert the thoracic impedance variations into absolute values of Tidal&#xD;
      volumes, the airway flow signal will be collected with a pneumotacograph during the NIV with&#xD;
      bucco-nasal mask session. The following data will also be collected : respiratory rate,&#xD;
      comfort, regional Tidal volume in dependent and non-dependent areas and global inhomogeneity&#xD;
      index, Pa02, PaCO2 and pH (If an arterial catheter is present). Signed consent will be&#xD;
      required prior to any inclusion.&#xD;
&#xD;
      Expected benefits : This study will provide a better understanding of P-Sili and help define&#xD;
      the place each non-invasive oxygenation techniques in the management of de novo acute&#xD;
      respiratory failure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">March 1, 2018</start_date>
  <completion_date type="Anticipated">September 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Tidal volume</measure>
    <time_frame>Averaged value over the last 3 minutes of thoracic impedance recording</time_frame>
    <description>in milliliter</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pH</measure>
    <time_frame>After 15 minutes of using a non invasive oxygenation device</time_frame>
    <description>Arterial blood gases will be collected only if an arterial catheter will be already inserted</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PaO2</measure>
    <time_frame>After 15 minutes of using a non invasive oxygenation device</time_frame>
    <description>in mm Hg; Arterial blood gases will be collected only if an arterial catheter will be already inserted</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PaCO2</measure>
    <time_frame>After 15 minutes of using a non invasive oxygenation device</time_frame>
    <description>in mm Hg; Arterial blood gases will be collected only if an arterial catheter will be already inserted</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory rate</measure>
    <time_frame>After 15 minutes of using a non invasive oxygenation device</time_frame>
    <description>in cycle/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comfort</measure>
    <time_frame>After 15 minutes of using a non invasive oxygenation device</time_frame>
    <description>using a semiquantitative scale from 1 (the worst comfort) to 5 (the best comfort)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Regional Tidal volume</measure>
    <time_frame>Averaged value over the last 3 minutes of thoracic impedance recording</time_frame>
    <description>in milliliter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global inhomogeneity index</measure>
    <time_frame>Averaged value over the last 3 minutes of thoracic impedance recording</time_frame>
    <description>in percentage</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Respiratory Failure With Hypoxia</condition>
  <arm_group>
    <arm_group_label>De novo AHRF</arm_group_label>
    <description>Acute hypoxemic non hypercapnic respiratory failure with a PaO2/FiO2 ratio &lt; 200.&#xD;
The following oxygenation devices are used and assessed during routine care:&#xD;
High concentration mask, High flow nasal canula, NIV using buco-nasal mask or Helmet.&#xD;
Electro impedence tomography signal will be recorded throughout this assessement for tidal volume measurement</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tidal volume measurement</intervention_name>
    <description>Recording of thoracic impendance variations during different non-invasive oxygenation techniques.&#xD;
Conversion to Tidal volume after calibration using the airway flow signal recorded during the NIV with bucco-nasal mask.</description>
    <arm_group_label>De novo AHRF</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with de novo acute hypoxemic respiratory failure&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Respiratory rate &gt; 25 per minute&#xD;
&#xD;
          -  PaO2/FiO2 &lt; 200 mmHg&#xD;
&#xD;
          -  PaCO2 &lt; 45 mmHg&#xD;
&#xD;
          -  Signed consent by patient or relative&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic respiratory disease&#xD;
&#xD;
          -  COPD exacerbation&#xD;
&#xD;
          -  Acute asthma&#xD;
&#xD;
          -  Cardiogenic pulmonary edema&#xD;
&#xD;
          -  Hemodynamic instability (systolic blood pressure &lt; 90 mmHg or mean blood pressure &lt; 65&#xD;
             mmHg or use of catecholamines)&#xD;
&#xD;
          -  Coma (Glasgow coma scale &lt; 12)&#xD;
&#xD;
          -  Contraindication to non-invasive ventilation&#xD;
&#xD;
          -  Indication to immediate intubation according to the physician&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guillaume Carteaux, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Henri Mondor University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guillaume Carteaux, MD, PhD</last_name>
    <phone>+ 33 (0)1 49 8123 91</phone>
    <email>guilaume.carteaux@aphp.fr</email>
  </overall_contact>
  <verification_date>February 2018</verification_date>
  <study_first_submitted>February 19, 2018</study_first_submitted>
  <study_first_submitted_qc>February 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 26, 2018</study_first_posted>
  <last_update_submitted>February 28, 2018</last_update_submitted>
  <last_update_submitted_qc>February 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Henri Mondor University Hospital</investigator_affiliation>
    <investigator_full_name>Dr Guillaume CARTEAUX</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

